Health ❯Diabetes

Type 2 Diabetes

Type 2 Diabetes Pharmaceuticals Obesity Clinical Trials Patient Care Public Health Diabetes Medications Pharmacology Weight Management

17 ARTICLES

3w ago

GLP-1 Drugs Found to Cut Alcohol Consumption and Improve Mental Health

New research presented at the European Congress on Obesity highlights the potential of GLP-1 receptor agonists to reduce alcohol intake by nearly two-thirds and enhance mood and quality of life in obese adults.

3 ARTICLES

4w ago

Study Investigates Vision Loss in Patients Using Popular Diabetes and Weight Loss Drugs

3 ARTICLES

4mo ago

FDA Approves Ozempic to Reduce Kidney Disease Risks in Type 2 Diabetes Patients

Type 2 Diabetes

GLP-1 Drugs Found to Cut Alcohol Consumption and Improve Mental Health

Eric Stonestreet Opens Up About Type 2 Diabetes Journey and Mounjaro's Impact

Dual Brain Receptor Targeting Shows Promise for Enhanced Obesity Treatment

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

Novo Nordisk Acquires Chinese Obesity Drug After CagriSema Trial Disappointment

Eli Lilly Launches Mounjaro in India to Address Obesity and Diabetes

Megan Stalter Criticizes Ozempic Use for Weight Loss

Study Investigates Vision Loss in Patients Using Popular Diabetes and Weight Loss Drugs

FDA Approves Ozempic to Reduce Kidney Disease Risks in Type 2 Diabetes Patients